Stockreport

4D Molecular Therapeutics Announces Pricing of Upsized Public Offering of Common Stock

4D Molecular Therapeutics, Inc.  (FDMT) 
PDF EMERYVILLE, Calif., Feb. 06, 2024 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics, Inc. (Nasdaq: FDMT), a leading clinical-stage genetic medicines company focused on unl [Read more]